Parkwood LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

Parkwood LLC’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-597	Closed	-$293K	–	356
2017 Q2	$293K	Buy	+597	New	+$261K	0.04%	306
2016 Q3	–	Sell	-634	Closed	-$221K	–	519
2016 Q2	$221K	Hold	634	–	–	0.04%	421
2016 Q1	$229K	Sell	634 -704	-53%	-$290K	0.04%	442
2015 Q4	$726K	Hold	1,338	–	–	0.11%	107
2015 Q3	$622K	Buy	+1,338	New	+$719K	0.1%	120
2014 Q3	–	Sell	-809	Closed	-$229K	–	299
2014 Q2	$229K	Buy	+809	New	+$240K	0.05%	121
2014 Q1	–	Sell	-566	Closed	-$156K	–	377
2013 Q4	$156K	Buy	+566	New	+$163K	0.04%	301

Other funds holding REGN

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Loomis, Sayles & Company

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return